RecallRadar

FDA Drug recall D-1287-2014

Lupron Depot (Leuprolide Acetate for Depot Suspension) Single Dose Administration Kit with prefilled dual-chamber syringe, 22.5 mg for 3-mo…

On 2014-05-07 the FDA classified a Class II recall of Lupron Depot (Leuprolide Acetate for Depot Suspension) Single Dose Administration Kit with prefilled dual-chamber syringe, 22.5 mg for 3-mo… by Abbvie, citing defective Delivery System: Some Lupron Depot Kits may contain a syringe with a potentially defective LuproLoc needle stick protection device.

Read the official FDA Drug notice

AgencyFDA Drug
Recall numberD-1287-2014
ClassificationClass II
Statusterminated
Initiated2014-03-10
Published2014-05-07
Last updated2026-09-13 11:51 UTC
CompanyAbbvie
DistributionUS

Product

Lupron Depot (Leuprolide Acetate for Depot Suspension) Single Dose Administration Kit with prefilled dual-chamber syringe, 22.5 mg for 3-month administration, Rx only, Manufactured for: AbbVie Inc., North Chicago, IL 60064; by: Takeda Pharmaceutical Company Limited, Osaka, Japan 540-8645; NDC 0074-3346-03, UPC 3 00743 34603 9.

Reason

Defective Delivery System: Some Lupron Depot Kits may contain a syringe with a potentially defective LuproLoc needle stick protection device.

Identifiers

upc300743346039
ndc0074-3473-03
ndc0074-3473-55
ndc0074-9945-01
ndc0074-0009-01
ndc0074-3683-03
ndc0074-3683-55
ndc0074-9930-01
ndc0074-3642-03
ndc0074-3642-55
ndc0074-9907-01
ndc0074-3346-03
ndc0074-3346-55
ndc0074-9922-01
code_infoLot #: 1014204, Exp 10/11/15; 1014485, Exp 12/11/16; and 1015007, Exp 12/06/16

Status history

No status changes recorded since RecallRadar first saw this recall on 2026-09-13 11:51 UTC. Current status: terminated.

Source

Official record: https://api.fda.gov/drug/enforcement.json?search=recall_number:%22D-1287-2014%22

RecallRadar indexes public recall notices from the FDA, USDA FSIS, and CPSC. The official agency notice is the authoritative source. Always confirm details at the linked source before acting.